FI952141A0 - Molekyylimerkintä käyttäen 2-hydraninopyridiinijohdannaisia - Google Patents
Molekyylimerkintä käyttäen 2-hydraninopyridiinijohdannaisiaInfo
- Publication number
- FI952141A0 FI952141A0 FI952141A FI952141A FI952141A0 FI 952141 A0 FI952141 A0 FI 952141A0 FI 952141 A FI952141 A FI 952141A FI 952141 A FI952141 A FI 952141A FI 952141 A0 FI952141 A0 FI 952141A0
- Authority
- FI
- Finland
- Prior art keywords
- pct
- compound
- hydraninopyridine
- derivatives
- date
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Cosmetics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Adhesives Or Adhesive Processes (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9223168 | 1992-11-05 | ||
| GB929223168A GB9223168D0 (en) | 1992-11-05 | 1992-11-05 | Improvements in molecule labelling |
| GB9302259 | 1993-02-05 | ||
| PCT/GB1993/002259 WO1994010149A1 (en) | 1992-11-05 | 1993-11-03 | Molecule labelling using 2-hydraninopyridine derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI952141A FI952141A (fi) | 1995-05-04 |
| FI952141A0 true FI952141A0 (fi) | 1995-05-04 |
| FI113044B FI113044B (fi) | 2004-02-27 |
Family
ID=10724568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI952141A FI113044B (fi) | 1992-11-05 | 1995-05-04 | 2-hydratsinopyridiinijohdannaisia |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5679778A (fi) |
| EP (1) | EP0667859B1 (fi) |
| JP (1) | JP3542597B2 (fi) |
| KR (1) | KR100295545B1 (fi) |
| AT (1) | ATE195730T1 (fi) |
| AU (1) | AU676863B2 (fi) |
| CA (1) | CA2148595C (fi) |
| DE (1) | DE69329293T2 (fi) |
| DK (1) | DK0667859T3 (fi) |
| ES (1) | ES2150950T3 (fi) |
| FI (1) | FI113044B (fi) |
| GB (1) | GB9223168D0 (fi) |
| GR (1) | GR3034883T3 (fi) |
| HK (1) | HK1013420A1 (fi) |
| HU (1) | HU226459B1 (fi) |
| NO (1) | NO305364B1 (fi) |
| NZ (1) | NZ257376A (fi) |
| PT (1) | PT667859E (fi) |
| WO (1) | WO1994010149A1 (fi) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5942210A (en) * | 1994-11-15 | 1999-08-24 | Cytogen Corporation | Methods for lyoprotecting a macromolecule using tricine |
| US5919934A (en) * | 1997-02-19 | 1999-07-06 | The George Washington University | Compounds, compositions, and methods for cancer imaging and therapy |
| WO1998048699A1 (en) | 1997-04-30 | 1998-11-05 | The Board Of Trustees Of The Leland Stanford Junior University | Method of imaging cell death in vivo |
| US6403054B1 (en) | 1997-05-28 | 2002-06-11 | Bristol-Myers Squibb Pharma Company | Ternary ligand complexes useful as radiopharmaceuticals |
| US6844333B1 (en) * | 1999-03-26 | 2005-01-18 | The Trustees Of The University Of Pennsylvania | Method of treating atherosclerosis |
| US6686461B1 (en) | 2000-03-22 | 2004-02-03 | Solulink Bioscience, Inc. | Triphosphate oligonucleotide modification reagents and uses thereof |
| US7102024B1 (en) | 2000-08-01 | 2006-09-05 | Schwartz David A | Functional biopolymer modification reagents and uses thereof |
| AU2001247697B2 (en) * | 2000-03-22 | 2006-06-22 | Solulink, Incorporated | Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| WO2002080754A2 (en) | 2001-04-03 | 2002-10-17 | Theseus Imaging Corporation | Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| WO2002082044A2 (en) | 2001-04-03 | 2002-10-17 | The Board Of Trustees Of The Leland Stanford Junior University | Method of imaging cell death in vivo |
| GB0130845D0 (en) * | 2001-12-22 | 2002-02-06 | James Peter | Analysis |
| US7158353B2 (en) * | 2003-11-06 | 2007-01-02 | Seagate Technology Llc | Magnetoresistive sensor having specular sidewall layers |
| JP5107716B2 (ja) | 2004-11-05 | 2012-12-26 | ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア | 分子治療用生分解性リンカー |
| AU2012213753B2 (en) * | 2011-01-31 | 2016-09-01 | Eth Zurich | Trifunctional crosslinking reagents |
| WO2012167088A1 (en) | 2011-06-03 | 2012-12-06 | 3M Innovative Properties Company | Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom |
| EP3366311B1 (en) | 2011-06-03 | 2020-02-26 | 3M Innovative Properties Co. | Hydrazino-1h-imidazoquinolin-4-amines and conjugates made therefrom |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4861869A (en) * | 1986-05-29 | 1989-08-29 | Mallinckrodt, Inc. | Coupling agents for joining radionuclide metal ions with biologically useful proteins |
| IL93432A (en) * | 1989-02-24 | 1994-02-27 | Johnson Mathey Inc | Hydrazines and hydrazides, their conjugates with macromolecules, and such conjugates labeled with metallic ions |
| US5112953A (en) * | 1989-12-29 | 1992-05-12 | Neorx Corporation | Radiolabeled proteins for diagnostic or therapeutic use |
-
1992
- 1992-11-05 GB GB929223168A patent/GB9223168D0/en active Pending
-
1993
- 1993-11-03 AU AU53755/94A patent/AU676863B2/en not_active Expired
- 1993-11-03 CA CA002148595A patent/CA2148595C/en not_active Expired - Lifetime
- 1993-11-03 AT AT93924157T patent/ATE195730T1/de active
- 1993-11-03 US US08/432,204 patent/US5679778A/en not_active Expired - Lifetime
- 1993-11-03 EP EP93924157A patent/EP0667859B1/en not_active Expired - Lifetime
- 1993-11-03 ES ES93924157T patent/ES2150950T3/es not_active Expired - Lifetime
- 1993-11-03 DK DK93924157T patent/DK0667859T3/da active
- 1993-11-03 JP JP51085194A patent/JP3542597B2/ja not_active Expired - Lifetime
- 1993-11-03 DE DE69329293T patent/DE69329293T2/de not_active Expired - Lifetime
- 1993-11-03 NZ NZ257376A patent/NZ257376A/en not_active IP Right Cessation
- 1993-11-03 KR KR1019950701810A patent/KR100295545B1/ko not_active IP Right Cessation
- 1993-11-03 HU HU9501275A patent/HU226459B1/hu unknown
- 1993-11-03 WO PCT/GB1993/002259 patent/WO1994010149A1/en active IP Right Grant
- 1993-11-03 PT PT93924157T patent/PT667859E/pt unknown
-
1995
- 1995-05-04 NO NO951751A patent/NO305364B1/no not_active IP Right Cessation
- 1995-05-04 FI FI952141A patent/FI113044B/fi not_active IP Right Cessation
-
1998
- 1998-12-22 HK HK98114895A patent/HK1013420A1/xx not_active IP Right Cessation
-
2000
- 2000-11-22 GR GR20000402572T patent/GR3034883T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1013420A1 (en) | 1999-08-27 |
| HUT72332A (en) | 1996-04-29 |
| EP0667859B1 (en) | 2000-08-23 |
| AU5375594A (en) | 1994-05-24 |
| AU676863B2 (en) | 1997-03-27 |
| GB9223168D0 (en) | 1992-12-16 |
| JPH08502744A (ja) | 1996-03-26 |
| ES2150950T3 (es) | 2000-12-16 |
| PT667859E (pt) | 2001-02-28 |
| KR100295545B1 (ko) | 2001-09-17 |
| NO951751L (no) | 1995-06-12 |
| HU226459B1 (en) | 2008-12-29 |
| NO951751D0 (no) | 1995-05-04 |
| ATE195730T1 (de) | 2000-09-15 |
| NO305364B1 (no) | 1999-05-18 |
| JP3542597B2 (ja) | 2004-07-14 |
| FI113044B (fi) | 2004-02-27 |
| CA2148595C (en) | 2002-05-21 |
| EP0667859A1 (en) | 1995-08-23 |
| US5679778A (en) | 1997-10-21 |
| WO1994010149A1 (en) | 1994-05-11 |
| FI952141A (fi) | 1995-05-04 |
| DK0667859T3 (da) | 2000-10-16 |
| DE69329293D1 (de) | 2000-09-28 |
| KR950704256A (ko) | 1995-11-17 |
| DE69329293T2 (de) | 2000-12-28 |
| GR3034883T3 (en) | 2001-02-28 |
| CA2148595A1 (en) | 1994-05-11 |
| NZ257376A (en) | 1996-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI952141A0 (fi) | Molekyylimerkintä käyttäen 2-hydraninopyridiinijohdannaisia | |
| NO20003133D0 (no) | Anilidderivater, fremstilling og anvendelse derav | |
| FI914163A0 (fi) | Heterocykliska derivat. | |
| NO20031490L (no) | Alifatisk nitrogenholdig 5-kantet ring-forbindelse | |
| DE69840296D1 (de) | Phenylethylenamin-derivate | |
| KR850003402A (ko) | 2-아미노-5-하이드록시-4-메틸 피리미딘 유도체의 제조방법 | |
| KR940000447A (ko) | 티아졸의 분지쇄 알킬아미노유도체, 그의 제조방법 및 그를 함유하는 약제학적 조성물 | |
| FI903917A0 (fi) | Foerfarande foer framstaellning av med metallradionuklider maerkta proteiner. | |
| CA2176935A1 (fr) | Arylpiperazines derivees d'indole comme ligands pour les recepteurs 5 ht1-like 5 ht1b et 5 ht1d | |
| ES2104682T3 (es) | Fluor-compuestos. | |
| CA2211385A1 (en) | N-1-carboxyalkyl derivatives of lsd | |
| DE50004382D1 (de) | Verfahren zur Herstellung von Guanidinderivaten | |
| ATE80388T1 (de) | Verfahren zur herstellung von 5-gliedrigen, stickstoffhaltigen heteroaromaten. | |
| BR9610804A (pt) | Processo para preparar um composto composto e sal dissódico | |
| ES2099963T3 (es) | Sintesis de indoles mediante deshidrogenacion de indolinas. | |
| FR2645535B1 (fr) | Preparation d'ethenes substitues | |
| KR850001204A (ko) | 1,4-디하이드로피리딘 유도체의 제조방법 | |
| KR960704889A (ko) | 인돌리진 유도체의 제조방법 (Process for the preparation of indolizine derivatives) | |
| KR920004377A (ko) | 피리딘카복실산 아미드 유도체 및 이를 함유하는 약제학적 조성물 | |
| TH16053A (fi) | ||
| TW352391B (en) | Novel cyanine dyes, the intermediates and preparation thereof | |
| KR940014350A (ko) | 신규 1, 6-디아미노 피리미딘-4-티온 유도체 및 이의 제조방법 | |
| KR910011892A (ko) | 디펩타이드유도체의 제조방법 | |
| KR870007879A (ko) | 노르보르난계 술폰아미드 유도체의 제조방법 | |
| KR930021636A (ko) | 2,4-디하이드로-3h-1,2,4-트리아졸-3-온 유도체의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assigment of application |
Owner name: ANORMED INC. |
|
| MA | Patent expired |